Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Platt currently holds 20,038,903 shares of Boston Therapeutics, Inc. (BTHE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Platt has been a net buyer of BTHE stock. They have purchased $208.5K and sold $56.5K worth of shares.
David Platt's most recent insider trade was on Oct 24, 2024, when they sold 14,085,410 shares at $0.29 per share.
David Platt serves as Executive at Boston Therapeutics, Inc. (BTHE). They have executed 80 insider transactions totaling $265.0K over their tenure at the company.
David Platt holds the position of Executive at Boston Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
David Platt has shown a buying trading pattern, with $208.5K in total purchases and $56.5K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by David Platt was on Oct 24, 2024, when they sold $6.3M worth of BIXT shares. This transaction involved 11,433,448 shares at $0.55 per share.
David Platt currently owns 20,038,903 shares of Boston Therapeutics, Inc. (BTHE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Platt's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Platt has 80 Form 4 filings on record as an insider at Boston Therapeutics, Inc..
Set alerts for David Platt and 40,000+ other insiders.